Susquehanna International Group, LLP Aerie Pharmaceuticals Inc Put Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Put Options

15 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Nov 14, 2022	BUY	$6.37 - $15.23 $95,550 - $228,450	15,000 New	15,000 $227,000
Q3 2021 Nov 15, 2021	SELL	$11.32 - $16.63 $173,196 - $254,438	-15,300 Reduced 57.95%	11,100 $127,000
Q3 2020 Nov 16, 2020	BUY	$10.46 - $14.46 $7,322 - $10,122	700 Added 2.72%	26,400 $311,000
Q2 2020 Aug 14, 2020	SELL	$12.0 - $16.13 $1.11 Million - $1.49 Million	-92,500 Reduced 78.26%	25,700 $379,000
Q1 2020 May 15, 2020	BUY	$11.84 - $25.52 $985,088 - $2.12 Million	83,200 Added 237.71%	118,200 $1.6 Million
Q4 2019 Feb 14, 2020	SELL	$17.72 - $25.1 $464,263 - $657,620	-26,200 Reduced 42.81%	35,000 $846,000
Q3 2019 Nov 14, 2019	BUY	$18.41 - $28.0 $165,690 - $252,000	9,000 Added 17.24%	61,200 $1.18 Million
Q2 2019 Aug 14, 2019	SELL	$28.97 - $48.21 $208,584 - $347,112	-7,200 Reduced 12.12%	52,200 $1.54 Million
Q1 2019 May 15, 2019	SELL	$36.32 - $49.25 $897,104 - $1.22 Million	-24,700 Reduced 29.37%	59,400 $2.82 Million
Q4 2018 Feb 14, 2019	BUY	$33.0 - $60.04 $13,200 - $24,016	400 Added 0.48%	84,100 $3.04 Million
Q3 2018 Nov 14, 2018	SELL	$56.15 - $73.9 $387,435 - $509,910	-6,900 Reduced 7.62%	83,700 $5.15 Million
Q2 2018 Aug 14, 2018	BUY	$47.85 - $70.45 $1.31 Million - $1.93 Million	27,400 Added 43.35%	90,600 $6.12 Million
Q1 2018 May 15, 2018	SELL	$51.15 - $61.0 $2.21 Million - $2.64 Million	-43,200 Reduced 40.6%	63,200 $3.43 Million
Q4 2017 Feb 14, 2018	SELL	$50.85 - $65.1 $6.33 Million - $8.1 Million	-124,400 Reduced 53.9%	106,400 $6.36 Million
Q3 2017 Nov 14, 2017	BUY	$48.6 - $60.1 $11.2 Million - $13.9 Million	230,800	230,800 $11.2 Million

Others Institutions Holding AERI

# of Institutions

Shares Held

2.4M

Call Options Held

Put Options Held

View Full List

About AERIE PHARMACEUTICALS INC

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

More about AERI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account